We just received data on a new analyst forecast for $HCAT. Piper Sandler gave a rating of 'Neutral' for $HCAT.
$HCAT Analyst Ratings
Wall Street analysts have issued reports on $HCAT in the last several months. We have seen 3 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Wells Fargo issued a "Overweight" rating on 08/11/2025
- Canaccord Genuity issued a "Buy" rating on 05/08/2025
- Keybanc issued a "Overweight" rating on 04/16/2025
To track analyst ratings and price targets for $HCAT, check out Quiver Quantitative's $HCAT forecast page.
$HCAT Price Targets
Multiple analysts have issued price targets for $HCAT recently. We have seen 9 analysts offer price targets for $HCAT in the last 6 months, with a median target of $4.5.
Here are some recent targets:
- Jessica Tassan from Piper Sandler set a target price of $4.0 on 08/27/2025
- Stan Berenshteyn from Wells Fargo set a target price of $6.0 on 08/11/2025
- David Grossman from Stifel set a target price of $4.5 on 08/08/2025
- Sarah James from Cantor Fitzgerald set a target price of $4.0 on 08/08/2025
- Daniel Grosslight from Citigroup set a target price of $3.5 on 08/08/2025
- Elizabeth Anderson from Evercore ISI Group set a target price of $4.0 on 07/09/2025
- Richard Close from Canaccord Genuity set a target price of $9.0 on 05/08/2025
$HCAT Insider Trading Activity
$HCAT insiders have traded $HCAT stock on the open market 5 times in the past 6 months. Of those trades, 0 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $HCAT stock by insiders over the last 6 months:
- DANIEL LESUEUR (Chief Operating Officer) has made 0 purchases and 3 sales selling 27,320 shares for an estimated $119,266.
- BENJAMIN LANDRY (General Counsel) has made 0 purchases and 2 sales selling 19,884 shares for an estimated $86,750.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HCAT Hedge Fund Activity
We have seen 70 institutional investors add shares of $HCAT stock to their portfolio, and 97 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DAVENTRY GROUP, LP removed 2,509,480 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $11,367,944
- WELLINGTON MANAGEMENT GROUP LLP removed 2,085,392 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $7,861,927
- WHETSTONE CAPITAL ADVISORS, LLC added 2,026,278 shares (+118.8%) to their portfolio in Q2 2025, for an estimated $7,639,068
- FIRST LIGHT ASSET MANAGEMENT, LLC added 1,793,374 shares (+17.2%) to their portfolio in Q2 2025, for an estimated $6,761,019
- PORTOLAN CAPITAL MANAGEMENT, LLC added 663,330 shares (+50.4%) to their portfolio in Q2 2025, for an estimated $2,500,754
- PENN CAPITAL MANAGEMENT COMPANY, LLC removed 495,945 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,246,630
- GRANAHAN INVESTMENT MANAGEMENT, LLC removed 493,364 shares (-100.0%) from their portfolio in Q1 2025, for an estimated $2,234,938
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
